BeOne Medicines Ltd.
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302252% above fair value
$361.27−9.06 (-2.45%)
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines PP&E Gross — Buildings: $1,205M in Q2 2026, up 29.2% from a year earlier. That is the highest of the 32 quarters on record here.
Latest, Q2 2026
1,205
Period ended Jun 30, 2026
Change on a year earlier
+29.2%
933 in Q2 2025
History
32 quarters
Since Q4 2017
Sources
31
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Property, Plant & Equipment Note (XBRL).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). BeOne Medicines PP&E Gross — Buildings ($M), quarterly Q4 2017–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/ppe-buildings
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.